Standigm will create advanced AI models using Nashville Biosciences’ de-identified genomic and clinical data. The data sets will help identify therapeutic targets, accelerate treatment development and improve patient outcomes, according to an Aug. 10 press release from Standigm.
The models are meant to assist with accelerating early-stage drug discovery and understanding the relationship between genetic variants and corresponding phenotypes. Additionally, incorporating large-scale data into the AI platforms will allow Standigm customers to leverage data of interest without collecting the data themselves.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
